MIV Therapeutics

MIV is a research and development company pursuing the commercialization of the next generation of biocompatible coatings for Stents and advanced drug delivery systems with the intent of providing healing solutions for CVD. Founded in 2003 as BioSync India Pvt Ltd , was subsequently acquired by MIV Therapeutics Inc, Atlanta, U.S in  September 2006 and established as MIV Therapeutics (I) Pvt Ltd. In 2011, Purple Medical Solution Pvt. Ltd, acquired MIV Therapeutics (I) Pvt Ltd and now manage global operations.

MIV  has developed coating technologies that utilize Hydroxyapatite, polymer-free coatings and advanced polymeric coatings with enhanced biocompatibility and bioavailability for application on medical devices and drug delivery systems in Coordination with MIV Technologies Inc, Vancouver & British Columbia University.

We have below mention products in our portfolio. Please visit www.mivtindia.com for further information.

1: genXSync - Cobalt Chromium based Sirolimus Eluting Coronary Stent with biodegradable polymer

2: Protea - Cobalt Chromium Coronary Stent System

3: genX - Stainless Steel Coronary Stent System

4: Accurex: Inflation Device + Y-Connector + Insertion Tool + Torquer

In case you are looking to add our product range & would like to discuss a possible path for distributing of our products in your region with mutual benefit. We are also looking for OEM partners.

Looking forward to hear from you.

Ms. Dhara Bhatt
Manager – Global Operations
Skype: dhara.bhatt28 | BBM Pin: 25ADAF40